Finance

Lists
SNTI:NASDAQ
Senti Biosciences Holdings Inc
$0.45
+16.93%
(+0.065) 1D
$0.42
-6.41% (-0.029)
After hours
Closed: Aug 14, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNTI...
Open
$0.40
High
$0.47
Low
$0.39
Mkt. cap
14.13M
Avg. vol.
303.29K
Volume
608.60K
52-wk high
$2.88
52-wk low
$0.33
EPS
-$1.92
Beta
2.10
Shares outstanding
31.14M
No. of employees
39
Open
$0.40
High
$0.47
Low
$0.39
Mkt. cap
14.13M
Avg. vol.
303.29K
Volume
608.60K
52-wk high
$2.88
52-wk low
$0.33
EPS
-$1.92
Beta
2.10
Shares outstanding
31.14M
No. of employees
39
News stories
From web sources and news partners
About Senti Biosciences Holdings Inc
CEO-
Employees39
Founded2016
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitesentibio.com
Analyst ratings
Based on 2 analysts giving stock ratings to SNTI in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for SNTI in the last 3 months.
Highest
Current $0.45
$12.00 (+2,572.61%)
Average
$12.00 (+2,572.61%)
Lowest
$12.00 (+2,572.61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$12.00
+2,572.6%
05/15/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$12.00
+2,572.6%
05/15/2026
Jeffrey La Rosa
Leerink Partners
Buy
Maintained
-
-
12/15/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
22.00K
16.00K
Cost of goods sold
10.03M
10.52M
7.76M
218.00K
Cost of revenue
10.03M
10.52M
7.76M
218.00K
Research and development expenses
-
-
-
5.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.18M
8.00M
423.00K
6.15M
Operating expense
5.18M
8.00M
423.00K
11.22M
Total operating expenses
15.21M
18.52M
8.18M
11.43M
Operating income
-15.21M
-18.52M
-8.16M
-11.42M
Other non operating income
209.00K
223.00K
-1.35M
214.00K
EBT including unusual items
-14.73M
-18.13M
-14.47M
-4.22M
EBT excluding unusual items
-14.73M
-18.13M
-9.42M
-11.10M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.73M
-18.13M
-14.47M
-4.22M
Net profit margin
-
-
-65,759.09%
-26,381.25%
Earnings per share
-0.56
-0.69
-0.53
-0.14
Interest and investment income
270.00K
166.00K
97.00K
101.00K
Interest expense
-
-
-
-
Net interest expenses
270.00K
166.00K
97.00K
101.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.30M
-17.61M
-7.27M
-10.73M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps